Navigation Links
BioSpecifics Technologies Corp. to Present at SEVEN, Noble Financial Capital Markets' Seventh Annual Equity Conference
Date:5/11/2011

LYNBROOK, N.Y., May 11, 2011 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at SEVEN, Noble Financial Capital Markets' Seventh Annual Equity Conference on Tuesday, May 17th at 9:30am EDT at the Hard Rock Hotel in Hollywood, Florida.

A live webcast of the presentation can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com, or you may use the link: http://noble.mediasite.com/mediasite/Viewer/?peid=546a50205ba1497a9a06f4122a1b3f071d.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications, three of which include: Dupuytren's contracture, Peyronie's disease, and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium Pharmaceuticals, Inc. markets XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture. Pfizer, Inc. is responsible for marketing XIAPEX® in Europe and has announced European regulatory approval and the first commercial sale in the United Kingdom. Asahi Kasei Pharma Corporation is responsible for marketing XIAFLEX® in Japan. More information about BioSpecifics Technologies Corp. may be found on its website at www.biospecifics.com.


'/>"/>
SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytrens Contracture in Europe
2. BioSpecifics Technologies Corp. to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference
3. BioSpecifics Technologies Corp. Amends Its Rights Agreement
4. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
5. BioSpecifics Technologies Corp. Awarded Two Qualifying Therapeutic Discovery Project Grants
6. BioSpecifics Technologies Corp. to Present at BioCentury Newsmakers in the Biotech Industry Conference
7. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010
9. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
10. BioSpecifics Technologies Corp. to Present at Jefferies & Company 2010 Global Life Sciences Conference
11. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2010 Financial Results on May 7, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016  Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... BSX ) has filed a lawsuit for patent ... Court for the District of Delaware ... covering technology related to stimulation leads, batteries, and telemetry ...
(Date:12/9/2016)... MSD, a nationally recognized supplier of technology ... site health care facilities, announced today that it has ... Choice"), a privately held national distributor of medical supplies ... health segments. We would like to welcome First Choice ... transaction will deliver significant and immediate value to MSD,s ...
(Date:12/9/2016)... , December 9, 2016 ... ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy ... Wearable Cardioverter Defibrillators The global ... a CAGR of 5.3% from 2016-2020 and CAGR ... to grow at a CAGR of 5.2% from ...
Breaking Medicine Technology:
(Date:12/10/2016)... ... 09, 2016 , ... Even with breast cancer cited as ... recent years. This can be attributed to the improvement in breast cancer care. ... In response, Mediaplanet’s latest, cross-platform edition of “Breast Cancer Care” spotlights the unmet ...
(Date:12/10/2016)... , ... December 10, 2016 , ... ... lists for Santa are all sources of external stimuli that can put a ... the added pressure to spread holiday cheer through gifts, food and festive gatherings ...
(Date:12/10/2016)... ... , ... "TransPanel Volume 2 is a package of fading panel transitions that ... of Pixel Film Studios. , TransPanel Volume 2 is a set of fading ... versatile transitions features presets with up to 4 panels with complementary line animations. ...
(Date:12/10/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) continues ... healthcare organizations to promote diabetes education at the World Diabetes Day observance. The ... speakers from around the Commonwealth of Pennsylvania. Speakers included Dr. Renu Joshi ...
(Date:12/10/2016)... (PRWEB) , ... December 10, 2016 , ... ... the most vulnerable population in Syria’s civil war—babies and toddlers. , The situation ... out. Families are experiencing bombing, facing starvation, and dying from disease. The situation ...
Breaking Medicine News(10 mins):